{
  "trial_id": "NCT03517579",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Graves' disease confirmed by laboratory testing",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "able to understand English and follow instructions",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "intermediate and high risk differentiated thyroid cancer requiring radioiodine remnant ablation or moderately high dose I-131 for treatment of residual cervical disease",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "able to understand simple English and follow instructions",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "diseases involving cervical spine, such as spondylosis and severe degenerative joint disease",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "pregnant Women",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "elderly",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "persons unable to understand simple instructions",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has metastatic papillary thyroid cancer, which may be a contraindication for the trial. Additionally, patient's age and ability to follow instructions are not clear indicators of eligibility.",
  "_meta": {
    "topic_id": "11",
    "trial_id": "NCT03517579",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}